Back to Trials
NCT02315729Recruiting

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis

University of Colorado, Denver

Start Date

11/1/2016

Completion Date

12/1/2028

Summary

The purpose of this study is to identify potential markers for curve progression in adolescent idiopathic scoliosis (AIS). Despite its prevalence and impact on child health, the etiology of AIS and molecular mechanisms underlying its development and progression remain poorly understood. Clinical criteria and features cannot adequately predict which children, diagnosed with mild disease, will undergo subsequent curve progression requiring intervention. The investigators hypothesize that alterations in specific genetic markers will be correlated with the progression of AIS curves over time. Thus, these markers could be used in the future to develop a reliable, inexpensive and relatively non-invasive cell based diagnostic test to (1) predict spinal curve progression in AIS, (2) select patients likely to benefit from early surgical intervention, and (3) potentially screen for asymptomatic children at risk of developing idiopathic scoliosis.

Eligibility Criteria

Age Range: 10 years to 13 years

Inclusion Criteria: * Females aged 10-13 years * Diagnosed with mild-moderate spine deformity (Cobb angle 15-30 degrees) Exclusion Criteria: * Patients with scoliosis other than idiopathic * Trauma * Inflammatory disease * Malignancies * Diabetes * History of previous spine surgery

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Adolescent Idiopathic Scoliosis

Locations

Children'S Hospital of Colorado

Denver, Colorado 80045

United States